
Vivani Medical
(NASDAQ) VANI
Vivani Medical Financials at a Glance
Market Cap
$110.38M
Revenue (TTM)
$0.00
Net Income (TTM)
-$27.09M
EPS (TTM)
-$0.40
P/E Ratio
-3.17
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$1.18
Volume
157,261.256
Open
$1.26
Price
$1.18
Volume
157,261.256
Open
$1.26
Previous Close
$1.18
Daily Range
$1.17 - $1.26
52-Week Range
$0.92 - $1.92
Estimated Earnings Date
Aug 12, 2026
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$1.18
Volume
157,261.256
Open
$1.26
Previous Close
$1.18
Daily Range
$1.17 - $1.26
52-Week Range
$0.92 - $1.92
Estimated Earnings Date
Aug 12, 2026
VANI News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vivani Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
42
CEO
Adam Mendelsohn, PhD
Website
www.vivani.comHeadquarters
Alameda, CA 94608, US
VANI Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-176%
Return on Capital
-78%
Return on Assets
-64%
Earnings Yield
-31.55%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$110.38M
Shares Outstanding
86.24M
Volume
157.26K
Avg. Volume
246.03K
Financials (TTM)
Gross Profit
-$424.00K
Operating Income
-$27.56M
EBITDA
-$27.13M
Operating Cash Flow
-$24.32M
Capital Expenditure
-$1.17M
Free Cash Flow
-$25.49M
Cash & ST Invst.
$16.23M
Total Debt
$18.86M
Vivani Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$130.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$110.38M
N/A
Market Cap/Employee
$2.98M
N/A
Employees
37
N/A
Net Income
-$6.78M
-7.6%
EBITDA
-$6.69M
-3.6%
Quarterly Fundamentals
Net Cash
$1.47M
+124.8%
Accounts Receivable
$12.00K
-93.1%
Inventory
$0.00
N/A
Long Term Debt
$16.49M
-6.4%
Short Term Debt
$1.78M
+35.9%
Return on Assets
-63.96%
N/A
Return on Invested Capital
-78.18%
N/A
Free Cash Flow
-$6.20M
-19.9%
Operating Cash Flow
-$6.20M
-20.0%